vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Fastly, Inc. (FSLY). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $172.6M, roughly 1.6× Fastly, Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs -9.0%, a 105.3% gap on every dollar of revenue. On growth, Fastly, Inc. posted the faster year-over-year revenue change (22.8% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 13.7%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Fastly, Inc. is an American company based in San Francisco, which describes itself as a cloud computing company. Fastly provides content delivery network services, image optimization, and load balancing services. Fastly's cloud security services include denial-of-service attack protection, bot mitigation, and a web application firewall.
ACAD vs FSLY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $172.6M |
| Net Profit | $273.6M | $-15.5M |
| Gross Margin | 90.8% | 61.4% |
| Operating Margin | 6.1% | -8.7% |
| Net Margin | 96.3% | -9.0% |
| Revenue YoY | 9.4% | 22.8% |
| Net Profit YoY | 90.3% | 52.9% |
| EPS (diluted) | $1.61 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $172.6M | ||
| Q3 25 | $278.6M | $158.2M | ||
| Q2 25 | $264.6M | $148.7M | ||
| Q1 25 | $244.3M | $144.5M | ||
| Q4 24 | $259.6M | $140.6M | ||
| Q3 24 | $250.4M | $137.2M | ||
| Q2 24 | $242.0M | $132.4M | ||
| Q1 24 | $205.8M | $133.5M |
| Q4 25 | $273.6M | $-15.5M | ||
| Q3 25 | $71.8M | $-29.5M | ||
| Q2 25 | $26.7M | $-37.5M | ||
| Q1 25 | $19.0M | $-39.1M | ||
| Q4 24 | $143.7M | $-32.9M | ||
| Q3 24 | $32.8M | $-38.0M | ||
| Q2 24 | $33.4M | $-43.7M | ||
| Q1 24 | $16.6M | $-43.4M |
| Q4 25 | 90.8% | 61.4% | ||
| Q3 25 | 92.2% | 58.4% | ||
| Q2 25 | 92.2% | 54.5% | ||
| Q1 25 | 91.7% | 53.2% | ||
| Q4 24 | 91.6% | 53.4% | ||
| Q3 24 | 92.5% | 54.5% | ||
| Q2 24 | 92.5% | 55.1% | ||
| Q1 24 | 88.8% | 54.8% |
| Q4 25 | 6.1% | -8.7% | ||
| Q3 25 | 12.8% | -18.2% | ||
| Q2 25 | 12.2% | -24.8% | ||
| Q1 25 | 7.9% | -26.4% | ||
| Q4 24 | 59.1% | -24.4% | ||
| Q3 24 | 12.6% | -29.6% | ||
| Q2 24 | 12.6% | -35.3% | ||
| Q1 24 | 7.4% | -34.6% |
| Q4 25 | 96.3% | -9.0% | ||
| Q3 25 | 25.8% | -18.6% | ||
| Q2 25 | 10.1% | -25.2% | ||
| Q1 25 | 7.8% | -27.1% | ||
| Q4 24 | 55.4% | -23.4% | ||
| Q3 24 | 13.1% | -27.7% | ||
| Q2 24 | 13.8% | -33.0% | ||
| Q1 24 | 8.0% | -32.5% |
| Q4 25 | $1.61 | $-0.10 | ||
| Q3 25 | $0.42 | $-0.20 | ||
| Q2 25 | $0.16 | $-0.26 | ||
| Q1 25 | $0.11 | $-0.27 | ||
| Q4 24 | $0.86 | $-0.23 | ||
| Q3 24 | $0.20 | $-0.27 | ||
| Q2 24 | $0.20 | $-0.32 | ||
| Q1 24 | $0.10 | $-0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $361.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $929.6M |
| Total Assets | $1.6B | $1.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $361.8M | ||
| Q3 25 | $258.0M | $342.9M | ||
| Q2 25 | $253.6M | $321.2M | ||
| Q1 25 | $217.7M | $307.3M | ||
| Q4 24 | $319.6M | $295.9M | ||
| Q3 24 | $155.1M | $308.2M | ||
| Q2 24 | $177.1M | $311.8M | ||
| Q1 24 | $204.7M | $329.5M |
| Q4 25 | $1.2B | $929.6M | ||
| Q3 25 | $917.3M | $937.0M | ||
| Q2 25 | $822.4M | $942.6M | ||
| Q1 25 | $765.2M | $957.0M | ||
| Q4 24 | $732.8M | $965.3M | ||
| Q3 24 | $577.2M | $969.5M | ||
| Q2 24 | $516.7M | $981.2M | ||
| Q1 24 | $464.0M | $991.8M |
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.3B | $1.5B | ||
| Q2 25 | $1.2B | $1.5B | ||
| Q1 25 | $1.1B | $1.4B | ||
| Q4 24 | $1.2B | $1.5B | ||
| Q3 24 | $976.9M | $1.5B | ||
| Q2 24 | $914.1M | $1.5B | ||
| Q1 24 | $855.1M | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $22.4M |
| Free Cash FlowOCF − Capex | — | $12.2M |
| FCF MarginFCF / Revenue | — | 7.1% |
| Capex IntensityCapex / Revenue | — | 5.9% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $65.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $22.4M | ||
| Q3 25 | $74.3M | $28.9M | ||
| Q2 25 | $64.0M | $25.8M | ||
| Q1 25 | $20.3M | $17.3M | ||
| Q4 24 | $40.4M | $5.2M | ||
| Q3 24 | $63.2M | $5.0M | ||
| Q2 24 | $25.0M | $-4.9M | ||
| Q1 24 | $29.1M | $11.1M |
| Q4 25 | — | $12.2M | ||
| Q3 25 | $73.9M | $22.9M | ||
| Q2 25 | — | $15.9M | ||
| Q1 25 | — | $14.7M | ||
| Q4 24 | — | $251.0K | ||
| Q3 24 | $63.2M | $3.0M | ||
| Q2 24 | — | $-6.7M | ||
| Q1 24 | — | $9.5M |
| Q4 25 | — | 7.1% | ||
| Q3 25 | 26.5% | 14.5% | ||
| Q2 25 | — | 10.7% | ||
| Q1 25 | — | 10.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 25.2% | 2.2% | ||
| Q2 24 | — | -5.1% | ||
| Q1 24 | — | 7.1% |
| Q4 25 | — | 5.9% | ||
| Q3 25 | 0.1% | 3.8% | ||
| Q2 25 | — | 6.6% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | 0.0% | 1.5% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 1.2% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
FSLY
| Network Services | $130.8M | 76% |
| Security | $35.4M | 21% |
| Other | $6.4M | 4% |
